Direxion Daily S&P Biotech Bull 3x Shares Rating $70.30 -0.01 (-0.01%) Closing price 04:10 PM EasternExtended Trading$70.38 +0.08 (+0.11%) As of 06:30 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ratings Stock AnalysisChartDividendHoldingsOwnershipRatingsShort InterestBuy This Stock Direxion Daily S&P Biotech Bull 3x Shares Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.LABU Aggregate RatingModerate Buy 2.70Holdings in LABU have an aggregate rating of Moderate Buy based on 410 analyst ratings issued in the past year covering 20 companies (30.3% of the portfolio).LABU Aggregate Price Target$70.09High Prediction$70.09Average Prediction$70.09Low Prediction$70.09Holdings in LABU have an aggregate price target of $70.09 and a range of $70.09 to $70.09 covering 20 companies (30.3% of the portfolio).LABU Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy3 Buy rating(s)Moderate Buy12 Moderate Buy rating(s)Hold5 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Direxion Daily S&P Biotech Bull 3x Shares Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 20 LABU Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings2.15%ALNYAlnylam Pharmaceuticals$452.33-0.4%4.1618 of 5 stars2.85$405.33 -10.4%26Positive News1.86%INSMInsmed$134.97+0.3%3.8825 of 5 stars2.94$132.57 -1.8%171.80%INCYIncyte$83.70-1.3%4.6676 of 5 stars2.33$81.60 -2.5%181.78%HALOHalozyme Therapeutics$72.81-0.5%4.7047 of 5 stars2.18$67.11 -7.8%11News CoveragePositive News1.62%UTHRUnited Therapeutics$307.24+0.6%4.9273 of 5 stars2.69$382.00 24.3%13News CoveragePositive NewsAnalyst Revision1.60%REGNRegeneron Pharmaceuticals$579.61-1.3%4.8516 of 5 stars2.81$817.67 41.1%27Trending NewsAnalyst Forecast1.55%GILDGilead Sciences$112.56-1.2%4.9733 of 5 stars2.88$115.39 2.5%26Positive News1.54%ABBVAbbVie$207.91-0.1%4.6992 of 5 stars2.96$214.95 3.4%27Trending NewsAnalyst Forecast1.53%NBIXNeurocrine Biosciences$138.94+0.6%4.8908 of 5 stars2.86$159.50 14.8%21Positive News1.50%BBIOBridgeBio Pharma$52.57+6.0%4.2208 of 5 stars3.00$61.35 16.7%171.49%BIIBBiogen$132.65-2.7%4.839 of 5 stars2.34$185.74 40.0%32Positive News1.45%AMGNAmgen$285.61-0.8%4.7439 of 5 stars2.33$304.43 6.6%21Positive NewsAnalyst Forecast1.44%BMRNBioMarin Pharmaceutical$57.68-1.7%4.9963 of 5 stars2.72$93.17 61.5%25Positive News1.44%MRNAModerna$24.47-2.5%4.4888 of 5 stars2.04$42.88 75.2%241.40%NTRANatera$167.88+3.0%3.1236 of 5 stars3.06$193.19 15.1%18Positive News1.35%MDGLMadrigal Pharmaceuticals$437.17+2.8%3.8663 of 5 stars2.90$459.25 5.1%10Analyst Forecast1.32%EXELExelixis$37.90-1.6%4.8776 of 5 stars2.52$44.06 16.2%23Positive NewsAnalyst Downgrade1.24%VRTXVertex Pharmaceuticals$392.05+0.8%4.9392 of 5 stars2.56$497.10 26.8%27Positive News1.17%EXASExact Sciences$46.95+0.5%4.9332 of 5 stars2.91$67.05 42.8%23Positive News1.04%ROIVRoivant Sciences$11.94-0.4%3.1844 of 5 stars3.25$16.50 38.2%4 This page (NYSEARCA:LABU) was last updated on 8/28/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | SponsoredThink you missed gold’s boom? Think againIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredThis is my Christian duty“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredBuffett, Gates and Bezos Quietly Dumping Stocks—Here's WhyImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | SponsoredIs This Stock the 'Next Nvidia'?'AI Bottleneck' Now Threatens Entire Magnificent 7 A new critical failure has appeared in the AI market, an...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Direxion Daily S&P Biotech Bull 3x Shares Please log in to your account or sign up in order to add this asset to your watchlist. Share Direxion Daily S&P Biotech Bull 3x Shares With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access